Market overview
The network point-of-care glucose testing market size was valued at USD 1,387.65 million in 2024, growing at a CAGR of 4.3% during 2025–2034.
Point-of-care glucose testing has long been central to diabetes management and acute care. The networked variant enhances the clinical utility of POC testing by enabling real-time data flow from testing devices to care teams and hospital information systems. This integration reduces manual transcription errors, supports protocols for insulin dosing, enables population management for at-risk cohorts, and generates longitudinal data for clinical decision support.
The market includes handheld and benchtop blood glucose meters with networking capability (Wi-Fi, Bluetooth, Ethernet), middleware and cloud platforms for data aggregation, EHR interfaces, and value-added services such as remote monitoring dashboards, analytics and device fleet management. Adoption is driven by hospitals modernizing information flows, outpatient clinics seeking tighter remote monitoring, and payers emphasizing outcomes and reduced readmission.
Key market growth drivers
- Clinical demand for safer, error-reduced workflows: Manual entry of glucose results is a persistent source of medication errors. Networked POC glucose systems automatically capture and transmit test results into EHRs and insulin-administration records, reducing transcription errors and improving glycemic control protocols. Improved patient safety is a strong clinical and regulatory incentive for adoption.
- Rise of value-based care and outcome-oriented reimbursement: Healthcare payers and systems increasingly tie reimbursement to outcomes such as reduced hypoglycemia, fewer complications, and decreased length of stay. Networked glucose testing enables tighter glycemic management and quality reporting, making it attractive to hospitals and integrated delivery networks focused on value-based metrics.
- Expansion of remote monitoring and home care models: Chronic disease management is shifting beyond hospital walls. Integrated POC devices and cloud platforms allow clinicians to monitor patients in transitional care, home health, and ambulatory settings. This shift supports earlier interventions, reduces emergency visits, and aligns with patient preference for care at home.
- Technological maturity and interoperability gains: Improvements in device connectivity, standardized data formats (HL7, FHIR), and middleware solutions have reduced integration barriers. The ability to securely share device data across EHRs, clinical decision support tools, and analytics platforms accelerates adoption and enables scalable deployments across health systems.
Major market challenges
- Data security and privacy concerns: Networked medical devices increase attack surfaces for cyber threats. Protecting patient data in transit and at rest, ensuring secure authentication, and meeting regional privacy regulations (such as HIPAA, GDPR-equivalent rules) remain top concerns for procurement and IT teams.
- Integration complexity with legacy systems: Despite progress in interoperability standards, many healthcare providers operate legacy EHRs and fragmented IT architectures. Integrating POC device data reliably across diverse systems can be costly and time-consuming, particularly for smaller facilities without robust IT departments.
- Regulatory and compliance hurdles: Medical device connectivity introduces questions around software validation, cybersecurity documentation, and clinical workflow validation. Regulatory scrutiny over software as a medical device (SaMD) and post-market surveillance adds compliance burdens for vendors and health systems.
- Total cost of ownership and procurement inertia: While networked POC systems deliver safety and operational benefits, initial acquisition costs, subscription fees for cloud services, and the need for staff training can delay investment. Hospital purchasing committees may favor phased rollouts, slowing market velocity.
Regional analysis
North America: The largest and most mature market due to high diabetes prevalence, advanced hospital IT infrastructure, and strong value-based care drivers. U.S. hospitals and integrated health systems lead adoption of networked POC platforms, with emphasis on inpatient glycemic control and perioperative management.
Europe: Adoption is steady across Western Europe where regulatory frameworks, national health systems and quality reporting encourage connected solutions. Countries with centralized procurement may see faster scaling once national guidelines endorse networked POC approaches. Data privacy regulation requires careful architectural planning.
Asia-Pacific: Rapid growth potential driven by increasing diabetes incidence, expanding private and public healthcare infrastructure, and growing investment in digital health. Markets such as Singapore, South Korea, Japan and Australia show early institutional uptake; emerging markets present greenfield opportunities but require cost-sensitive solutions and local regulatory navigation.
Latin America: Growth is moderate, led by larger hospitals in urban centers. Barriers include limited IT integration in smaller facilities and budget constraints. Strategic partnerships with regional healthcare organizations and payers can unlock adoption.
Middle East & Africa: Adoption is nascent but promising in private healthcare networks and tertiary centers. Investments in healthcare digitization programs create long-term opportunity, though fragmented systems and funding models present near-term challenges.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/network-point-of-care-glucose-testing-market
- ACON Laboratories, Inc.
- Abbott Laboratories
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- Danaher Corporation (HemoCue subsidiary)
- DexCom, Inc.
- EKF Diagnostics Holdings plc.
- F. Hoffmann-La Roche Ltd.
- LifeScan, Inc. (Platinum Equity Advisors, LLC subsidiary)
- Medtronic plc
- Nipro Corporation Japan
- Nova Biomedical Corporation
- Prodigy Diabetes Care, LLC
- Terumo Corporation
- Trividia Health, Inc.
Market outlook & strategic implications
The Network Point-of-Care Glucose market is expected to expand as healthcare systems prioritize connected diagnostics and safety. Vendors that succeed will combine reliable, regulated hardware with robust, secure connectivity and seamless EHR integration. Strategic partnerships with health systems, demonstrated reductions in medication error rates or hypoglycemia incidence, and flexible financing models will accelerate deployments.
Buyers should evaluate solutions across five domains: clinical accuracy and device usability; interoperability and standards support; cybersecurity and privacy controls; scalability and vendor support; and total cost of ownership including software services and training. Pilot implementations that measure clinical outcomes and workflow efficiency will de-risk broader rollouts.
More Trending Latest Reports By Polaris Market Research:
Thermal Insulation Coating Market
Fatty Methyl Ester Sulfonate Market
Automated Guided Vehicle (Agv) Market
Non-Small Cell Lung Cancer Market
Automotive Torque Converter Market
Automotive Torque Converter Market
